系统性炎症指标在心力衰竭中的应用
Application of Systemic Inflammation Markers in Heart Failure
摘要: 心力衰竭是多种心血管病的严重表现或中晚期阶段，是严重危及生命的临床综合征，具有发病率高、病死率高、住院率高、患者生活质量差以及医疗花费高等特点，努力减轻其造成的社会经济负担已成为全球公共卫生的主要优先事项。系统性炎症指标如中性粒细胞淋巴细胞比率(NLR)、淋巴细胞单核细胞比率(LMR)、血小板淋巴细胞比率(PLR)、全身性免疫炎症指数(SII)等已成为目前的研究热点，多项研究表明其与心血管疾病的发生发展有着紧密联系，同时易于计算和获取。现就系统性炎性指标在心力衰竭中的应用进行综述，加强对上述指标的监测有助于临床上预测心力衰竭的发生风险及预后。
Abstract: Heart failure is a severe manifestation or middle to late stage of a variety of cardiovascular diseases. It is a serious life-threatening clinical syndrome characterized by high morbidity, high mortality, high hospitalization rate, poor quality of life of patients and high medical costs. Efforts to reduce the socio-economic burden caused by heart failure have become a major global public health priority. Systemic inflammation indicators such as neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), platelet-to-lymphocyte ratio (PLR), and systemic immune inflammation index (SII) have become the focus of current research, and many studies have shown that they are closely related to the occurrence and development of cardiovascular diseases, and they are easy to calculate and obtain. This article reviews the application of systemic inflammatory indicators in heart failure. Strengthening the monitoring of these indicators is helpful to predict the risk and prognosis of heart failure in clinic.
文章引用：付茗婕, 周晓莉. 系统性炎症指标在心力衰竭中的应用[J]. 临床医学进展, 2024, 14(4): 2526-2532. https://doi.org/10.12677/acm.2024.1441324

参考文献

[1] Heidenreich, P.A., Bozkurt, B., Aguilar, D., et al. (2022) 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 145, e895-e1032. [Google Scholar] [CrossRef] 
[2] Savarese, G., Becher, P.M., Lund, L.H., et al. (2023) Global Burden of Heart Failure: A Comprehensive and Updated Review of Epidemiology. Cardiovascular Research, 118, 3272-3287. [Google Scholar] [CrossRef] [PubMed]
[3] 王华, 刘宇佳, 杨杰孚. 心力衰竭流行病学[J]. 临床心血管病杂志, 2023, 39(4): 243-247.
[4] Adamo, L., Rocha-Resende, C., Prabhu, S.D., et al. (2020) Reappraising the Role of Inflammation in Heart Failure. Nature Reviews Cardiology, 17, 269-285. [Google Scholar] [CrossRef] [PubMed]
[5] Haybar, H., Pezeshki, S.M.S. and Saki, N. (2019) Evaluation of Complete Blood Count Parameters in Cardiovascular Diseases: An Early Indicator of Prognosis? Experimental and Molecular Pathology, 110, Article ID: 104267. [Google Scholar] [CrossRef] [PubMed]
[6] Murphy, S.P., Kakkar, R., McCarthy, C.P., et al. (2020) Inflammation in Heart Failure: JACC State-of-the-Art Review. Journal of the American College of Cardiology, 75, 1324-1340. [Google Scholar] [CrossRef] [PubMed]
[7] Mantovani, A., Cassatella, M.A., Costantini, C., et al. (2011) Neutrophils in the Activation and Regulation of Innate and Adaptive Immunity. Nature Reviews Immunology, 11, 519-531. [Google Scholar] [CrossRef] [PubMed]
[8] Joseph, A.M., Monticelli, L.A. and Sonnenberg, G.F. (2018) Metabolic Regulation of Innate and Adaptive Lymphocyte Effector Responses. Immunological Reviews, 286, 137-147. [Google Scholar] [CrossRef] [PubMed]
[9] Ouyang, H., Xiao, B., Huang, Y., et al. (2023) Baseline and Early Changes in the Neutrophil-Lymphocyte Ratio (NLR) Predict Survival Outcomes in Advanced Colorectal Cancer Patients Treated with Immunotherapy. International Immunopharmacology, 123, Article ID: 110703. [Google Scholar] [CrossRef] [PubMed]
[10] Guo, Y., Xiang, D., Wan, J., et al. (2022) Focus on the Dynamics of Neutrophil-to-Lymphocyte Ratio in Cancer Patients Treated with Immune Checkpoint Inhibitors: A Meta-Analysis and Systematic Review. Cancers, 14, Article 5297. [Google Scholar] [CrossRef] [PubMed]
[11] Qiao, S., Gao, W. and Guo, S. (2020) Neutrophil-Lymphocyte Ratio (NLR) for Predicting Clinical Outcomes in Patients with Coronary Artery Disease and Type 2 Diabetes Mellitus: A Propensity Score Matching Analysis. Therapeutics and Clinical Risk Management, 16, 437-443. [Google Scholar] [CrossRef] 
[12] Zhan, L., Liu, Y., Cheng, Y., et al. (2021) Predictive Value of Neutrophil/Lymphocyte Ratio (NLR) on Cardiovascular Events in Patients with COVID-19. International Journal of General Medicine, 14, 3899-3907. [Google Scholar] [CrossRef] 
[13] Bai, B., Cheng, M., Jiang, L., et al. (2021) High Neutrophil to Lymphocyte Ratio and Its Gene Signatures Correlate with Diastolic Dysfunction in Heart Failure with Preserved Ejection Fraction. Frontiers in Cardiovascular Medicine, 8, Article 614757. [Google Scholar] [CrossRef] [PubMed]
[14] Liu, T., Wang, B., Xiao, S., et al. (2023) Correlation Analysis between the Static and the Changed Neutrophil-to-Lymphocyte Ratio and In-Hospital Mortality in Critical Patients with Acute Heart Failure. Postgraduate Medicine, 135, 50-57. [Google Scholar] [CrossRef] [PubMed]
[15] Tamaki, S., Nagai, Y., Shutta, R., et al. (2023) Combination of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as a Novel Predictor of Cardiac Death in Patients with Acute Decompensated Heart Failure with Preserved Left Ventricular Ejection Fraction: A Multicenter Study. Journal of the American Heart Association, 12, e026326. [Google Scholar] [CrossRef] 
[16] Zhu, X., Cheang, I., Xu, F., et al. (2022) Long-Term Prognostic Value of Inflammatory Biomarkers for Patients with Acute Heart Failure: Construction of an Inflammatory Prognostic Scoring System. Frontiers in Immunology, 13, Article 1005697. [Google Scholar] [CrossRef] [PubMed]
[17] García-Escobar, A., Vera-Vera, S., Tébar-Márquez, D., et al. (2023) Neutrophil-To-Lymphocyte Ratio an Inflammatory Biomarker, and Prognostic Marker in Heart Failure, Cardiovascular Disease and Chronic Inflammatory Diseases: New Insights for a Potential Predictor of Anti-Cytokine Therapy Responsiveness. Microvascular Research, 150, Article ID: 104598. [Google Scholar] [CrossRef] [PubMed]
[18] Gawiński, C., Michalski, W., Mróz, A., et al. (2022) Correlation between Lymphocyte-to-Monocyte Ratio (LMR), Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR) and Tumor-Infiltrating Lymphocytes (TILs) in Left-Sided Colorectal Cancer Patients. Biology, 11, Article 385. [Google Scholar] [CrossRef] [PubMed]
[19] Lin, Z.Q., Ma, C., Cao, W.Z., et al. (2022) Prognostic Significance of NLR, PLR, LMR and Tumor Infiltrating T Lymphocytes in Patients Undergoing Surgical Resection for Hilar Cholangiocarcinoma. Frontiers in Oncology, 12, Article 908907. [Google Scholar] [CrossRef] [PubMed]
[20] Chen, S., Zhang, J., Qian, C., et al. (2023) Prognostic Value of Combined LMR and CEA Dynamic Monitoring in Postoperative Colorectal Cancer Patients. Journal of Inflammation Research, 16, 4229-4250. [Google Scholar] [CrossRef] 
[21] Liu, Z., Xv, Y., Liu, X. and Zhou, X.L. (2022) Associations of Systemic Inflammatory Markers with the Risks of Chronic Heart Failure: A Case-Control Study. Clinics, 77, Article ID: 100056. [Google Scholar] [CrossRef] [PubMed]
[22] Wang, R., Wu, J., Ye, H., et al. (2022) Application Value of Systemic Inflammatory Indexes in the Clinical Evaluation of Patients with Heart Failure with Preserved Ejection Fraction (HFpEF). Medicina, 58, Article 1473. [Google Scholar] [CrossRef] [PubMed]
[23] Feldman, C. and Anderson, R. (2020) Platelets and Their Role in the Pathogenesis of Cardiovascular Events in Patients with Community-Acquired Pneumonia. Frontiers in Immunology, 11, Article 577303. [Google Scholar] [CrossRef] [PubMed]
[24] Saad, H., Soliman, H.A., Mahmoud, B., et al. (2023) the Pathogenic Role of Oxidative Stress, Cytokine Expression, and Impaired Hematological Indices in Diabetic Cardiovascular Diseases. Inflammation, 46, 146-160. [Google Scholar] [CrossRef] [PubMed]
[25] Liu, D., Czigany, Z., Heij, L.R., et al. (2022) The Value of Platelet-to-Lymphocyte Ratio as a Prognostic Marker in Cholangiocarcinoma: A Systematic Review and Meta-Analysis. Cancers, 14, Article 438. [Google Scholar] [CrossRef] [PubMed]
[26] Zhou, K., Cao, J., Lin, H., et al. (2022) Prognostic Role of the Platelet to Lymphocyte Ratio (PLR) in the Clinical Outcomes of Patients with Advanced Lung Cancer Receiving Immunotherapy: A Systematic Review and Meta-Analysis. Frontiers in Oncology, 12, Article 962173. [Google Scholar] [CrossRef] [PubMed]
[27] Zhai, G., Wang, J., Liu, Y., et al. (2021) Platelet-Lymphocyte Ratio as a New Predictor of In-Hospital Mortality in Cardiac Intensive Care Unit Patients. Scientific Reports, 11, Article No. 23578. [Google Scholar] [CrossRef] [PubMed]
[28] Intan, R.E., Alkaff, F.F., Oktaviono, Y.H., et al. (2022) Retrospective Study of the Association between Platelet-to-Lymphocyte Ratio in Patients with Acute Coronary Syndrome on Admission to a Rural Referral Center in East Java, Indonesia, and the Incidence of New Symptomatic Heart Failure at 6 Months. Medical Science Monitor, 28, e935002. [Google Scholar] [CrossRef] 
[29] Powrózek, T., Skwarek-Dziekanowska, A., Sobieszek, G., et al. (2024) Correlation between Neutrophil-to-Lymphocyte Ratio, Platelets-to-Lymphocyte Ratio, C-Reactive Protein-to-Albumin Ratio and Clinical Picture of Elderly Chronic Heart Failure Patients. Journal of Clinical Medicine, 13, Article 433. [Google Scholar] [CrossRef] [PubMed]
[30] Liu, Z., Zhang, R., Xv, Y., et al. (2022) A Novel Nomogram Integrated with Systemic Inflammation Markers and Traditional Prognostic Factors for Adverse Events’ Prediction in Patients with Chronic Heart Failure in the Southwest of China. Journal of Inflammation Research, 15, 6785-6800. [Google Scholar] [CrossRef] 
[31] Meng, L., Yang, Y., Hu, X., et al. (2023) Prognostic Value of the Pretreatment Systemic Immune-Inflammation Index in Patients with Prostate Cancer: A Systematic Review and Meta-Analysis. Journal of Translational Medicine, 21, Article No. 79. [Google Scholar] [CrossRef] [PubMed]
[32] Huang, T., Peng, Q., Zhang, Y., et al. (2024) The Systemic Immune-Inflammation Index (SII) and Coronary Artery Lesions in Kawasaki Disease. Clinical and Experimental Medicine, 24, Article No. 4. [Google Scholar] [CrossRef] [PubMed]
[33] Wang, H., Nie, H., Bu, G., et al. (2023) Systemic Immune-Inflammation Index (SII) and the Risk of All-Cause, Cardiovascular, and Cardio-Cerebrovascular Mortality in the General Population. European Journal of Medical Research, 28, Article No. 575. [Google Scholar] [CrossRef] [PubMed]
[34] Yang, Y.L., Wu, C.H., Hsu, P.F., et al. (2020) Systemic Immune-Inflammation Index (SII) Predicted Clinical Outcome in Patients with Coronary Artery Disease. European Journal of Clinical Investigation, 50, e13230. [Google Scholar] [CrossRef] [PubMed]
[35] Wang, Z., Qin, Z., Yuan, R., et al. (2023) Systemic Immune-Inflammation Index as a Prognostic Marker for Advanced Chronic Heart Failure with Renal Dysfunction. ESC Heart Failure, 10, 478-491. [Google Scholar] [CrossRef] [PubMed]
[36] Zheng, H., Yin, Z., Luo, X., et al. (2024) Associations between Systemic Immunity-Inflammation Index and Heart Failure: Evidence from the NHANES 1999-2018. International Journal of Cardiology, 395, Article ID: 131400. [Google Scholar] [CrossRef] [PubMed]

为你推荐